Literature DB >> 9619440

New ferromagnetic bone cement for local hyperthermia.

K Takegami1, T Sano, H Wakabayashi, J Sonoda, T Yamazaki, S Morita, T Shibuya, A Uchida.   

Abstract

We have developed a ferromagnetic bone cement as a thermoseed to generate heat by hysteresis loss under an alternate magnetic field. This material resembles bioactive bone cement in composition, with a portion of the bioactive glass ceramic component replaced by magnetite (Fe3O4) powder. The temperature of this thermoseed rises in proportion to the weight ratio of magnetite powder, the volume of the thermoseed, and the intensity of the magnetic field. The heat-generating ability of this thermoseed implanted into rabbit and human cadaver tibiae was investigated by applying a magnetic field with a maximum of 300 Oe and 100 kHz. In this system, it is very easy to increase the temperature of the thermoseed in bone beyond 50 degrees C by adjusting the above-mentioned control factors. When the temperature of the thermoseed in rabbit tibiae was maintained at 50 to 60 degrees C, the temperature at the interface between the bone and muscle (cortical surface) surrounding the material rose to 43 to 45 degrees C; but at a 10-mm distance from the thermoseed in the medullary canal, the temperature did not exceed 40 degrees C. These results demonstrate that ferromagnetic bone cement may be applicable for the hyperthermic treatment of bone tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9619440     DOI: 10.1002/(sici)1097-4636(199822)43:2<210::aid-jbm16>3.0.co;2-l

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  9 in total

1.  Injectable iron-modified apatitic bone cement intended for kyphoplasty: cytocompatibility study.

Authors:  M D Vlad; L J del Valle; I Poeata; M Barracó; J López; R Torres; E Fernández
Journal:  J Mater Sci Mater Med       Date:  2008-07-15       Impact factor: 3.896

Review 2.  A novel hyperthermia treatment for bone metastases using magnetic materials.

Authors:  Akihiko Matsumine; Kenji Takegami; Kunihiro Asanuma; Takao Matsubara; Tomoki Nakamura; Atsumasa Uchida; Akihiro Sudo
Journal:  Int J Clin Oncol       Date:  2011-03-04       Impact factor: 3.402

3.  Effect of the calcium to phosphorus ratio on the setting properties of calcium phosphate bone cements.

Authors:  M D Vlad; S Gómez; M Barracó; J López; E Fernández
Journal:  J Mater Sci Mater Med       Date:  2012-05-26       Impact factor: 3.896

4.  Smart magnetic poly(N-isopropylacrylamide) to control the release of bio-active molecules.

Authors:  Chiara Dionigi; Lisa Lungaro; Vitaly Goranov; Alberto Riminucci; Yolanda Piñeiro-Redondo; Manuel Bañobre-López; José Rivas; Valentin Dediu
Journal:  J Mater Sci Mater Med       Date:  2014-01-30       Impact factor: 3.896

5.  Novel hyperthermia for metastatic bone tumors with magnetic materials by generating an alternating electromagnetic field.

Authors:  Akihiko Matsumine; Katsuyuki Kusuzaki; Takao Matsubara; Ken Shintani; Haruhiko Satonaka; Toru Wakabayashi; Shinichi Miyazaki; Katsuya Morita; Kenji Takegami; Atsumasa Uchida
Journal:  Clin Exp Metastasis       Date:  2007-05-09       Impact factor: 4.510

6.  Effect of P2O5 and MnO2 on crystallization of magnetic glass ceramics.

Authors:  Salwa A M Abdel-Hameed; Mohamed A Marzouk; Mohamed M Farag
Journal:  J Adv Res       Date:  2013-07-17       Impact factor: 10.479

7.  The induction of hyperthermia in rabbit liver by means of duplex stainless steel thermoseeds.

Authors:  Byeong Ho Park; Bong Sig Koo; Young Kon Kim; Moon Kon Kim
Journal:  Korean J Radiol       Date:  2002 Apr-Jun       Impact factor: 3.500

8.  Hyperthermia using magnetite cationic liposomes for hamster osteosarcoma.

Authors:  Fumiko Matsuoka; Masashige Shinkai; Hiroyuki Honda; Tadahiko Kubo; Takashi Sugita; Takeshi Kobayashi
Journal:  Biomagn Res Technol       Date:  2004-03-25

Review 9.  Targeted Nanomedicine to Treat Bone Metastasis.

Authors:  Isaac M Adjei; Madison N Temples; Shannon B Brown; Blanka Sharma
Journal:  Pharmaceutics       Date:  2018-10-25       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.